1. Home
  2. SYRE vs WTTR Comparison

SYRE vs WTTR Comparison

Compare SYRE & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • WTTR
  • Stock Information
  • Founded
  • SYRE 2013
  • WTTR 2016
  • Country
  • SYRE United States
  • WTTR United States
  • Employees
  • SYRE N/A
  • WTTR N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • WTTR Oilfield Services/Equipment
  • Sector
  • SYRE Health Care
  • WTTR Energy
  • Exchange
  • SYRE Nasdaq
  • WTTR Nasdaq
  • Market Cap
  • SYRE 841.4M
  • WTTR 922.1M
  • IPO Year
  • SYRE 2016
  • WTTR 2017
  • Fundamental
  • Price
  • SYRE $14.10
  • WTTR $8.31
  • Analyst Decision
  • SYRE Buy
  • WTTR Strong Buy
  • Analyst Count
  • SYRE 8
  • WTTR 3
  • Target Price
  • SYRE $50.00
  • WTTR $16.17
  • AVG Volume (30 Days)
  • SYRE 553.9K
  • WTTR 1.3M
  • Earning Date
  • SYRE 05-08-2025
  • WTTR 05-06-2025
  • Dividend Yield
  • SYRE N/A
  • WTTR 3.39%
  • EPS Growth
  • SYRE N/A
  • WTTR N/A
  • EPS
  • SYRE N/A
  • WTTR 0.34
  • Revenue
  • SYRE N/A
  • WTTR $1,459,911,000.00
  • Revenue This Year
  • SYRE N/A
  • WTTR $5.30
  • Revenue Next Year
  • SYRE N/A
  • WTTR $7.19
  • P/E Ratio
  • SYRE N/A
  • WTTR $24.54
  • Revenue Growth
  • SYRE N/A
  • WTTR N/A
  • 52 Week Low
  • SYRE $10.91
  • WTTR $7.58
  • 52 Week High
  • SYRE $40.49
  • WTTR $15.14
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.32
  • WTTR 45.13
  • Support Level
  • SYRE $12.29
  • WTTR $7.20
  • Resistance Level
  • SYRE $15.77
  • WTTR $8.93
  • Average True Range (ATR)
  • SYRE 1.06
  • WTTR 0.41
  • MACD
  • SYRE 0.08
  • WTTR 0.01
  • Stochastic Oscillator
  • SYRE 52.08
  • WTTR 61.33

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About WTTR Select Water Solutions Inc.

Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.

Share on Social Networks: